245 related articles for article (PubMed ID: 16005602)
41. Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.
Roukos DH; Briasoulis E
Nat Clin Pract Oncol; 2007 Oct; 4(10):578-90. PubMed ID: 17898808
[TBL] [Abstract][Full Text] [Related]
42. Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.
Metcalfe KA; Poll A; O'Connor A; Gershman S; Armel S; Finch A; Demsky R; Rosen B; Narod SA
Clin Genet; 2007 Sep; 72(3):208-17. PubMed ID: 17718858
[TBL] [Abstract][Full Text] [Related]
43. Breast cancer genetic counseling after diagnosis but before treatment: a pilot study on treatment consequences and psychological impact.
Wevers MR; Hahn DE; Verhoef S; Bolhaar MD; Ausems MG; Aaronson NK; Bleiker EM
Patient Educ Couns; 2012 Oct; 89(1):89-95. PubMed ID: 22543000
[TBL] [Abstract][Full Text] [Related]
44. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
[TBL] [Abstract][Full Text] [Related]
45. Surgical treatment planning in newly diagnosed breast cancer patients at high risk for BRCA-1 or BRCA-2 mutation.
Chung MA; Cady B
Breast J; 2004; 10(6):473-4. PubMed ID: 15569200
[No Abstract] [Full Text] [Related]
46. Breast cancer after bilateral risk-reducing mastectomy.
Skytte AB; Crüger D; Gerster M; Laenkholm AV; Lang C; Brøndum-Nielsen K; Andersen MK; Sunde L; Kølvraa S; Gerdes AM
Clin Genet; 2011 May; 79(5):431-7. PubMed ID: 21199491
[TBL] [Abstract][Full Text] [Related]
47. Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy.
Metcalfe KA; Esplen MJ; Goel V; Narod SA
Psychooncology; 2004 Jan; 13(1):14-25. PubMed ID: 14745742
[TBL] [Abstract][Full Text] [Related]
48. Preoperative genetic testing affects surgical decision making in breast cancer patients.
Lokich E; Stuckey A; Raker C; Wilbur JS; Laprise J; Gass J
Gynecol Oncol; 2014 Aug; 134(2):326-30. PubMed ID: 24910453
[TBL] [Abstract][Full Text] [Related]
49. Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer.
Meiser B; Butow P; Price M; Bennett B; Berry G; Tucker K;
J Womens Health (Larchmt); 2003 Oct; 12(8):769-78. PubMed ID: 14588127
[TBL] [Abstract][Full Text] [Related]
50. Contralateral risk-reducing mastectomy in young women.
Merck B
Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():29-32. PubMed ID: 20711671
[No Abstract] [Full Text] [Related]
51. Perception of breast cancer risk and surveillance behaviours of women with family history of breast cancer: a brief report on a Spanish cohort.
Gil F; Méndez I; Sirgo A; Llort G; Blanco I; Cortés-Funes H
Psychooncology; 2003 Dec; 12(8):821-7. PubMed ID: 14681955
[TBL] [Abstract][Full Text] [Related]
52. Bilateral prophylactic mastectomy in Swedish women at high risk of breast cancer: a national survey.
Arver B; Isaksson K; Atterhem H; Baan A; Bergkvist L; Brandberg Y; Ehrencrona H; Emanuelsson M; Hellborg H; Henriksson K; Karlsson P; Loman N; Lundberg J; Ringberg A; Askmalm MS; Wickman M; Sandelin K
Ann Surg; 2011 Jun; 253(6):1147-54. PubMed ID: 21587115
[TBL] [Abstract][Full Text] [Related]
53. Use of breast MRI surveillance in women at high risk for breast cancer: a single-institutional experience.
Elmore L; Margenthaler JA
Ann Surg Oncol; 2010 Oct; 17 Suppl 3():263-7. PubMed ID: 20853044
[TBL] [Abstract][Full Text] [Related]
54. Psychological distress in women at increased risk for breast cancer: the role of risk perception.
van Dooren S; Rijnsburger AJ; Seynaeve C; Duivenvoorden HJ; Essink-Bot ML; Tilanus-Linthorst MM; de Koning HJ; Tibben A
Eur J Cancer; 2004 Sep; 40(14):2056-63. PubMed ID: 15341979
[TBL] [Abstract][Full Text] [Related]
55. Application of screening principles to the reconstructed breast.
Zakhireh J; Fowble B; Esserman LJ
J Clin Oncol; 2010 Jan; 28(1):173-80. PubMed ID: 19884555
[TBL] [Abstract][Full Text] [Related]
56. Bilateral prophylactic mastectomy decision making: A vignette study.
Stefanek M; Enger C; Benkendorf J; Flamm Honig S; Lerman C
Prev Med; 1999 Sep; 29(3):216-21. PubMed ID: 10479610
[TBL] [Abstract][Full Text] [Related]
57. A protocol for preventative mastectomy in women with an increased lifetime risk of breast cancer.
Lalloo F; Baildam A; Brain A; Hopwood P; Evans DG; Howell A
Eur J Surg Oncol; 2000 Nov; 26(7):711-3. PubMed ID: 11078619
[TBL] [Abstract][Full Text] [Related]
58. Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.
Hamilton JG; Genoff MC; Salerno M; Amoroso K; Boyar SR; Sheehan M; Fleischut MH; Siegel B; Arnold AG; Salo-Mullen EE; Hay JL; Offit K; Robson ME
Breast Cancer Res Treat; 2017 Apr; 162(2):297-306. PubMed ID: 28150129
[TBL] [Abstract][Full Text] [Related]
59. Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families.
Katapodi MC; Northouse LL; Milliron KJ; Liu G; Merajver SD
Psychooncology; 2013 Jun; 22(6):1336-43. PubMed ID: 22826208
[TBL] [Abstract][Full Text] [Related]
60. [Women with hereditary risk of breast cancer: consensus of surgical representatives of study groups for hereditary tumors regarding intensive monitoring, diagnosis and preventive resection].
van Geel AN; Rutgers EJ; Vos-Deckers GC; de Vries J; Wobbes T
Ned Tijdschr Geneeskd; 1997 May; 141(18):874-7. PubMed ID: 9273451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
